15 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderActive, not recruitingPhase 32026-10-06NCT07263776
Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseChronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 32026-09-28NCT07464587
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .Upper Limb Spasticity (ULS)RecruitingPhase 32026-09-23NCT07242300
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar LinesModerate to Severe Glabellar LinesRecruitingPhase 32026-09-23NCT06937944
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Strokebrain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingPhase 32026-09-09NCT07509645
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionHypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 32026-08-19NCT06829784
Efficacy and Safety of LT3001 on Treating the Acute Ischemic StrokeAcute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingPhase 22026-04-30NCT05686642
Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular EdemaDiabetic Macular Edema (DME)RecruitingPhase 32026-04-07NCT07515079
Modified Tumor-free Techniques Operation to Cervical CancerFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorderRecruitingNot applicable2026-03-27NCT06836869
the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished ChildrenChild Malnutrition, Child Nutrition Disorders, Nutritional and Metabolic Diseases, nutritional deficiency disease, nutritional disorderRecruitingNot applicable2026-03-18NCT05911893
A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress SyndromePostprandial Distress SyndromeRecruitingPhase 32026-01-20NCT06696261
A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic RhinitisHypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitisNot yet recruitingPhase 32025-08-28NCT07146126
Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathybackground diabetic retinopathyRecruitingPhase 32025-08-24NCT06817265
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progressioneye disorder, myopia, refractive errorRecruitingPhase 32024-12-24NCT06708156
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's DiseaseAlzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyRecruitingPhase 42023-11-09NCT05908695